AAAAAA
Results:
1-25
|
Results: 25
Authors:
JOLY V
CARBON C
Citation: V. Joly et C. Carbon, EDITORIAL RESPONSE - UNFORTUNATE IN-VITRO SELECTION OF RESISTANT CANDIDA-ALBICANS WITH SEVERE CLINICAL CONSEQUENCES, Clinical infectious diseases, 27(4), 1998, pp. 692-694
Authors:
DARRASJOLY C
LUCET JC
LAISSY JP
CHOCHILLON C
CASALINO E
JOLY V
MATHERON S
BOUVET E
Citation: C. Darrasjoly et al., INVASIVE ASPERGILLOSIS IN AIDS, Pathologie et biologie, 46(6), 1998, pp. 416-417
Authors:
JOLY V
BELMATOUG N
LEPERRE A
ROBERT J
JAULT F
CARBON C
YENI P
Citation: V. Joly et al., PACEMAKER ENDOCARDITIS DUE TO CANDIDA-ALBICANS - CASE-REPORT AND REVIEW, Clinical infectious diseases, 25(6), 1997, pp. 1359-1362
Authors:
ABGRALL S
JOLY V
DERKINDEREN P
DECRE D
CARBON C
YENI P
Citation: S. Abgrall et al., LACTOBACILLUS-CASEI INFECTION IN AN AIDS PATIENT, European journal of clinical microbiology & infectious diseases, 16(2), 1997, pp. 180-182
Authors:
JOLY V
MARMIGNON C
Citation: V. Joly et C. Marmignon, EFFECT OF H2O VAPOR ON THE VIBRATIONAL-RELAXATION IN HYPERSONIC WIND TUNNELS, Journal of thermophysics and heat transfer, 11(2), 1997, pp. 266-272
Authors:
SEUXLEVIEIL ML
JOLY V
YENI P
CARBON C
BLANCHET F
Citation: Ml. Seuxlevieil et al., EVALUATION OF RENAL ACIDIFICATION IN HIV-INFECTED PATIENTS WITH HYPERGAMMAGLOBULINEMIA, Nephron, 75(2), 1997, pp. 196-200
Authors:
JOLY V
Citation: V. Joly, INFECTION PROPHYLAXIS IN IMMUNOSUPPRESSED PATIENTS - PREVENTION OF TRANSFUSION-TRANSMITTED INFECTIONS, Annales de medecine interne, 148(3), 1997, pp. 268-271
Authors:
JOLY V
AUBRY P
NDAYIRAGIDE A
CARRIERE I
KAWA E
MLIKACABANNE N
ABOULKER JP
COULAUD JP
LAROUZE B
YENI P
Citation: V. Joly et al., RANDOMIZED COMPARISON OF AMPHOTERICIN-B DEOXYCHOLATE DISSOLVED IN DEXTROSE OR INTRALIPID FOR THE TREATMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS, Clinical infectious diseases, 23(3), 1996, pp. 556-562
Authors:
DARRASJOLY C
CHEVRET S
WOLFF M
MATHERON S
LONGUET P
CASALINO E
JOLY V
CHOCHILLON C
BEDOS JP
Citation: C. Darrasjoly et al., CRYPTOCOCCUS-NEOFORMANS INFECTION IN FRANCE - EPIDEMIOLOGIC FEATURES OF AND EARLY PROGNOSTIC PARAMETERS FOR 76 PATIENTS WHO WERE INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 23(2), 1996, pp. 369-376
Authors:
JOLY V
BELMATOUG N
SIBERT A
CARBON C
YENI P
Citation: V. Joly et al., SEPTIC THROMBOPHLEBITIS OF THE PORTAL-VEIN, Clinical infectious diseases, 23(2), 1996, pp. 417-418
Authors:
FANTIN B
JOLY V
ELBIM C
GOLMARD JL
GOUGEROTPOCIDALO MA
YENI P
CARBON C
Citation: B. Fantin et al., LYMPHOCYTE SUBSET COUNTS DURING THE COURSE OF COMMUNITY-ACQUIRED PNEUMONIA - EVOLUTION ACCORDING TO AGE, HUMAN-IMMUNODEFICIENCY-VIRUS STATUS, AND ETIOLOGIC MICROORGANISMS, Clinical infectious diseases, 22(6), 1996, pp. 1096-1098
Authors:
JOLY V
GEOFFRAY C
REYNES J
GOUJARD C
MECHALI D
MASLO C
RAFFI F
YENI P
Citation: V. Joly et al., AMPHOTERICIN-B IN A LIPID EMULSION FOR THE TREATMENT OF CRYPTOCOCCAL MENINGITIS IN AIDS PATIENTS, Journal of antimicrobial chemotherapy, 38(1), 1996, pp. 117-126
Authors:
CHEMLAL K
SAINTJULIEN L
JOLY V
FARINOTTI R
SETA N
YENI P
CARBON C
Citation: K. Chemlal et al., COMPARISON OF FLUCONAZOLE AND AMPHOTERICIN-B FOR TREATMENT OF EXPERIMENTAL CANDIDA-ALBICANS ENDOCARDITIS IN RABBITS, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 263-266
Authors:
JOLY V
KALFON P
POETE P
BODIN L
PUYBASSET L
CORIAT P
ROUBY JJ
Citation: V. Joly et al., USE OF THE SAME HEAT AND MOISTURE EXCHANGER FOR 48 H IN INTENSIVE-CARE UNIT VENTILATED PATIENTS, British Journal of Anaesthesia, 76, 1996, pp. 345-345
Authors:
BEENTIKTAK AMM
JOLY V
SITBON G
COLLIN G
DEVOS M
DEGRAAF L
DEHAAN C
BOUCHER C
BRUMVEZINET F
Citation: Amm. Beentiktak et al., COMBINATION THERAPY WITH DELAVIRDINE MESYLATE AND AZT - VIROLOGY DATAFROM A EUROPEAN PHASE-II TRIAL, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 48-48
Authors:
JOLY V
YENI P
Citation: V. Joly et P. Yeni, NUCLEOTIDE ANALOGS FOR TREATMENT OF HIV-I NFECTION - NEW DATA, La Presse medicale, 24(2), 1995, pp. 103
Authors:
JOLY V
Citation: V. Joly, VALUE OF ANIMAL-MODELS IN THE EVALUATION OF ANTIFUNGAL AGENTS, Medecine et maladies infectieuses, 25(BIS), 1995, pp. 27-31
Authors:
JOLY V
Citation: V. Joly, VALUE OF ANIMAL-MODELS IN THE EVALUATION OF ANTIFUNGAL AGENTS, Medecine et maladies infectieuses, 25, 1995, pp. 27-31
Authors:
JOLY V
Citation: V. Joly, BRITTANY DURING THE WAR, 1939-1945 - FREN CH - SAINCLIVIER,J, Annales de Bretagne et des pays de l'Ouest, 101(4), 1994, pp. 120-121
Authors:
JOLY V
Citation: V. Joly, PREVENTION OF INVASIVE ASPERGILLOSIS VALU E OF CHEMOPROPHYLAXIS, Pathologie et biologie, 42(7), 1994, pp. 694-699
Authors:
CHAVANET P
JOLY V
RIGAUD D
BOLARD J
CARBON C
YENI P
Citation: P. Chavanet et al., INFLUENCE OF DIET ON EXPERIMENTAL TOXICITY OF AMPHOTERICIN-B DEOXYCHOLATE, Antimicrobial agents and chemotherapy, 38(5), 1994, pp. 963-968
Authors:
JOLY V
FARINOTTI R
SAINTJULIEN L
CHERON M
CARBON C
YENI P
Citation: V. Joly et al., IN-VITRO RENAL TOXICITY AND IN-VIVO THERAPEUTIC EFFICACY IN EXPERIMENTAL MURINE CRYPTOCOCCOSIS OF AMPHOTERICIN-B (FUNGIZONE) ASSOCIATED WITH INTRALIPID, Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 177-183
Authors:
JOLY V
COQUEL F
MARMIGNON C
ARETZ W
METZ S
WILHELMI H
Citation: V. Joly et al., NUMERICAL MODELING OF HEAT-TRANSFER AND RELAXATION IN NONEQUILIBRIUM AIR AT HYPERSONIC SPEEDS, La Recherche aerospatiale, (3), 1994, pp. 219-234
Authors:
JOLY V
SAINTJULIEN L
CARBON C
YENI P
Citation: V. Joly et al., IN-VIVO ACTIVITY OF INTERFERON-GAMMA IN COMBINATION WITH AMPHOTERICIN-B IN THE TREATMENT OF EXPERIMENTAL CRYPTOCOCCOSIS, The Journal of infectious diseases, 170(5), 1994, pp. 1331-1334
Authors:
SABA J
MORLAT P
RAFFI F
HAZEBROUCQ V
JOLY V
LEPORT C
VILDE JL
Citation: J. Saba et al., PYRIMETHAMINE PLUS AZITHROMYCIN FOR TREATMENT OF ACUTE TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS, European journal of clinical microbiology & infectious diseases, 12(11), 1993, pp. 853-856
Risultati:
1-25
|